Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 60/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories Ltd. has announced that its Board of Directors will meet on November 5, 2024, to review and approve the unaudited financial results for the quarter and half-year ending September 30, 2024. Additionally, the company has declared that the trading window for its securities will be closed from September 24, 2024, until November 7, 2024, to comply with insider trading regulations. This meeting highlights the company's efforts toward transparency and regulatory adherence.

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled board meeting to approve financial results shows commitment to transparency.
  • Unaudited financial results can provide insights into company performance.
  • Effective management of insider trading regulations reflects corporate governance.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Intimation regarding Board Meeting
Pursuant to Regulation 29 of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate you that a meeting of the Board
of Directors of the Company will be held on Tuesday, November 5, 2024, inter alia, to consider and approve the Unaudited Financial
Results of the Company for the quarter and half year ending on September 30, 2024.
Further, kindly note that, under the provisions of
the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed
from September 24, 2024, to November 7, 2024 (both days inclusive).
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer and Head CSR

Frequently Asked Questions

When is the next Board Meeting for Dr. Reddy's Laboratories?

The Board Meeting is scheduled for November 5, 2024.

What will be discussed in the Board Meeting?

The meeting will focus on approving the Unaudited Financial Results.

What period do the financial results cover?

The financial results are for the quarter and half year ending September 30, 2024.

When will the trading window be closed?

The trading window will close from September 24 to November 7, 2024.

Who issued this communication?

The communication is from Dr. Reddy's Laboratories Limited's Company Secretary.

Last updated: Sep 22, 2024